It’s easy to get involved in research or join a clinical trial through the MMRF. Let us guide you through the process every step of the way.
More data on treatment of high risk SMM; Kyprolis/Revlimid/dex induction and consolidation, Rev/dex maintenance. 100% response rate in all high risk pts with 76% CR or better. #ASH19 #mmsm
Some interesting data on ASCT in MM pts over 70. Benefits for this older pt population are similar to that seen in younger pts; can't yet determine if these outcomes are better than non-transplant outcomes. #ASH19 #mmsm
Griffin study update: dara-RVd continues to improve response rates and depth of response compared to RVd
Wednesday, December 18th - 1:00pm ET
May 6, 2020 - Ziegfeld Ballroom
Chicago Awards Dinner
October 13, 2020 - Four Seasons Hotel Chicago